Completed OBSERVATIONAL NCT07121387
A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
A Real-World Retrospective Cohort Analysis of SMARCA4-Deficient Advanced Lung Cancer
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Updated 1 time since 2025 Last updated: Aug 6, 2025 Started: Jan 1, 2020 Primary completion: Dec 17, 2024 Completion: Dec 17, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07121387, this observational or N/A phase trial focuses on NSCLC (Advanced Non-small Cell Lung Cancer) and SMARCA4-Deficient Tumor and remains completed. Sponsored by Shanghai Pulmonary Hospital, Shanghai, China, it has been updated 1 time since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai Pulmonary Hospital, Shanghai, China
Data source: Shanghai Pulmonary Hospital, Shanghai, China
For direct contact, visit the study record on ClinicalTrials.gov .